- ABOUT STERITAS
- STERITAS GTI
- CLINICAL SCIENCE
Ever since the introduction of the Steritas Glucocorticoid Toxicity Instrument (GTI) in 2017, there has been a remarkable surge in the number of clinicians and clinical researchers using Steritas's ...
A recent phase 2 safety and efficacy study of an anti-interleukin-17A monoclonal antibody for the treatment of giant cell arteritis patients suggests there may soon be another alternative to ...